Related Experiment Videos
A rapid method for assessing megathrombocytes: its application to thrombocytotic and acquired thrombocytopenic states
Abstract:
A rapid technique suitable for routine laboratory use for determining the percentage of large platelets in the peripheral blood is described. In 50 haematologically normal subjects, megathrombocytes (platelets with a volume of 16-33 fl) constituted 3.0-16.6% (mean +/- 2 SD) of the platelet count. Of the 10 patients examined with immune thrombocytopenic purpura, an increased percentage of megathrombocytes (mean 26.6%) was found in all with severe thrombocytopenia, and in 6 of 8 (mean 19.8%) with moderate thrombocytopenia; the percentages were not influenced by prior splenectomy. Six of 12 patients with severe hypomegakaryocytic thrombocytopenia had an increased percentage of large platelets (mean 15.9%), as did one of 21 patients (mean 9.9%) with moderate thrombocytopenia of simimlar aetiology. When patients with nearly identical platelet counts were compared, the mean percentage of megathrombocytes was greater in immune than in hypomegakaryocytic thrombocytopenia for both severe (t=3.17, P less than 0.01) and moderate (t=4.5, P less than 0.001) thrombocytopenia. An increased percentage of large platelets (mean 21.9%) was found in 6 to 8 patients with disseminated intravascular coagulation, in 7 of 20 (mean 15.8%) with chronic myeloproliferative disorders and in one of 15 (mean 8.8%) with reactive thrombocytosis. Determination of the percentage of megathrombocytes by this technique assists in differentiating immune thrombocytopenia from hypomegakaryocytic thrombocytopenia, in diagnosing mild disseminated intravascular coagulation, and in determining whether thrombocytosis is reactive or a consequence of a myeloproliferative disorders.
Insights
A new rapid lab technique identifies large platelets (megathrombocytes) to help diagnose various platelet disorders. Elevated megathrombocyte percentages aid in differentiating immune vs. hypomegakaryocytic thrombocytopenia and diagnosing other conditions.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- Platelet volume is a key indicator in diagnosing and managing various hematological conditions.
- Differentiating causes of thrombocytopenia, such as immune destruction versus impaired production, is clinically significant.
- Assessing platelet size distribution can provide insights into thrombotic and myeloproliferative disorders.
Purpose of the Study:
- To describe a rapid laboratory technique for quantifying the percentage of large platelets (megathrombocytes) in peripheral blood.
- To evaluate the diagnostic utility of megathrombocyte percentage in distinguishing between different types of thrombocytopenia and other platelet-related disorders.
- To establish reference ranges for megathrombocyte percentages in healthy individuals.
Main Methods:
- A new, rapid laboratory method was developed for routine use.
- Peripheral blood samples were analyzed to determine the percentage of megathrombocytes (platelets with a volume of 16-33 fl).
- The technique was applied to healthy subjects and patients with immune thrombocytopenic purpura, hypomegakaryocytic thrombocytopenia, disseminated intravascular coagulation, myeloproliferative disorders, and reactive thrombocytosis.
Main Results:
- In normal subjects, megathrombocytes comprised 3.0-16.6% of the platelet count.
- Increased megathrombocyte percentages were observed in patients with immune thrombocytopenic purpura (severe and moderate) and hypomegakaryocytic thrombocytopenia.
- Elevated levels were also found in disseminated intravascular coagulation and chronic myeloproliferative disorders, distinguishing them from reactive thrombocytosis.
Conclusions:
- The described technique for determining megathrombocyte percentage is a valuable tool for routine laboratory use.
- It aids in differentiating immune thrombocytopenia from hypomegakaryocytic thrombocytopenia.
- It assists in diagnosing mild disseminated intravascular coagulation and characterizing the etiology of thrombocytosis.